265 related articles for article (PubMed ID: 24611928)
1. 1,2,3,4,8,9,10,11-octahydrobenzo[j]phenanthridine-7,12-diones as new leads against Mycobacterium tuberculosis.
Cappoen D; Claes P; Jacobs J; Anthonissen R; Mathys V; Verschaeve L; Huygen K; De Kimpe N
J Med Chem; 2014 Apr; 57(7):2895-907. PubMed ID: 24611928
[TBL] [Abstract][Full Text] [Related]
2. 2,4-Dialkyl-8,9,10,11-tetrahydrobenzo[g]pyrimido[4,5-c]isoquinoline-1,3,7,12(2H,4H)-tetraones as new leads against Mycobacterium tuberculosis.
Claes P; Cappoen D; Uythethofken C; Jacobs J; Mertens B; Mathys V; Verschaeve L; Huygen K; De Kimpe N
Eur J Med Chem; 2014 Apr; 77():409-21. PubMed ID: 24681334
[TBL] [Abstract][Full Text] [Related]
3. Straightforward palladium-mediated synthesis and biological evaluation of benzo[j]phenanthridine-7,12-diones as anti-tuberculosis agents.
Cappoen D; Jacobs J; Nguyen Van T; Claessens S; Diels G; Anthonissen R; Einarsdottir T; Fauville M; Verschaeve L; Huygen K; De Kimpe N
Eur J Med Chem; 2012 Feb; 48():57-68. PubMed ID: 22182928
[TBL] [Abstract][Full Text] [Related]
4. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
5. The synthesis and in vitro biological evaluation of novel fluorinated tetrahydrobenzo[j]phenanthridine-7,12-diones against Mycobacterium tuberculosis.
Cappoen D; Torfs E; Meiresonne T; Claes P; Semina E; Holvoet F; de Macedo MB; Cools F; Piller T; Matheeussen A; Van Calster K; Caljon G; Delputte P; Maes L; Neyrolles O; De Kimpe N; Mangelinckx S; Cos P
Eur J Med Chem; 2019 Nov; 181():111549. PubMed ID: 31376569
[TBL] [Abstract][Full Text] [Related]
6. Novel amide and sulphonamide derivatives of 6-(piperazin-1-yl)phenanthridine as potent Mycobacterium tuberculosis H37Rv inhibitors.
Naidu KM; Nagesh HN; Singh M; Sriram D; Yogeeswari P; Gowri Chandra Sekhar KV
Eur J Med Chem; 2015 Mar; 92():415-26. PubMed ID: 25590862
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents.
Pieroni M; Wan B; Cho S; Franzblau SG; Costantino G
Eur J Med Chem; 2014 Jan; 72():26-34. PubMed ID: 24333612
[TBL] [Abstract][Full Text] [Related]
8. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and evaluation of 6-(4-((substituted-1H-1,2,3-triazol-4-yl)methyl)piperazin-1-yl)phenanthridine analogues as antimycobacterial agents.
Nagesh HN; Naidu KM; Rao DH; Sridevi JP; Sriram D; Yogeeswari P; Chandra Sekhar KV
Bioorg Med Chem Lett; 2013 Dec; 23(24):6805-10. PubMed ID: 24169232
[TBL] [Abstract][Full Text] [Related]
10. Developing pyrrole-derived antimycobacterial agents: a rational lead optimization approach.
Biava M; Porretta GC; Poce G; Battilocchio C; Alfonso S; de Logu A; Manetti F; Botta M
ChemMedChem; 2011 Apr; 6(4):593-9. PubMed ID: 21341373
[TBL] [Abstract][Full Text] [Related]
11. Benzimidazole-based compounds kill Mycobacterium tuberculosis.
Gong Y; Somersan Karakaya S; Guo X; Zheng P; Gold B; Ma Y; Little D; Roberts J; Warrier T; Jiang X; Pingle M; Nathan CF; Liu G
Eur J Med Chem; 2014 Mar; 75():336-53. PubMed ID: 24556148
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationships for a series of quinoline-based compounds active against replicating and nonreplicating Mycobacterium tuberculosis.
Lilienkampf A; Mao J; Wan B; Wang Y; Franzblau SG; Kozikowski AP
J Med Chem; 2009 Apr; 52(7):2109-18. PubMed ID: 19271749
[TBL] [Abstract][Full Text] [Related]
13. Anti-mycobacterial activity of 1,3-diaryltriazenes.
Cappoen D; Vajs J; Uythethofken C; Virag A; Mathys V; Kočevar M; Verschaeve L; Gazvoda M; Polanc S; Huygen K; Košmrlj J
Eur J Med Chem; 2014 Apr; 77():193-203. PubMed ID: 24631899
[TBL] [Abstract][Full Text] [Related]
14. 6-hydrogen-8-methylquinolones active against replicating and non-replicating Mycobacterium tuberculosis.
Tabarrini O; Sabatini S; Massari S; Pieroni M; Franzblau SG; Cecchetti V
Chem Biol Drug Des; 2012 Nov; 80(5):781-6. PubMed ID: 22889240
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of anti-tubercular activity of 6-(4-substitutedpiperazin-1-yl) phenanthridine analogues.
Nagesh HN; Suresh N; Mahalakshmi Naidu K; Arun B; Padma Sridevi J; Sriram D; Yogeeswari P; Chandra Sekhar KV
Eur J Med Chem; 2014 Mar; 74():333-9. PubMed ID: 24486416
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in the research of heterocyclic compounds as antitubercular agents.
Yan M; Ma S
ChemMedChem; 2012 Dec; 7(12):2063-75. PubMed ID: 23042656
[TBL] [Abstract][Full Text] [Related]
17. 1,4-diarylpiperazines and analogs as anti-tubercular agents: synthesis and biological evaluation.
Forge D; Cappoen D; Laurent J; Stanicki D; Mayence A; Huang TL; Verschaeve L; Huygen K; Vanden Eynde JJ
Eur J Med Chem; 2012 Mar; 49():95-101. PubMed ID: 22301215
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and antimycobacterial activity of some novel imidazo[1,2-c]pyrimidines.
Chhabria MT; Jani MH
Eur J Med Chem; 2009 Oct; 44(10):3837-44. PubMed ID: 19423196
[TBL] [Abstract][Full Text] [Related]
19. A review on various heterocyclic moieties and their antitubercular activity.
Sharma S; Sharma PK; Kumar N; Dudhe R
Biomed Pharmacother; 2011 Jul; 65(4):244-51. PubMed ID: 21715130
[TBL] [Abstract][Full Text] [Related]
20. Preliminary structure-activity relationships and biological evaluation of novel antitubercular indolecarboxamide derivatives against drug-susceptible and drug-resistant Mycobacterium tuberculosis strains.
Onajole OK; Pieroni M; Tipparaju SK; Lun S; Stec J; Chen G; Gunosewoyo H; Guo H; Ammerman NC; Bishai WR; Kozikowski AP
J Med Chem; 2013 May; 56(10):4093-103. PubMed ID: 23611124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
